VivoSim Labs, Inc. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
VivoSim Labs, Inc. (VIVS) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of -$2.35 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-08-12
- 2026-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -$2.35M.
- 2026-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -$1.10M.
- 2025-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $4.44M.
- 2025-09-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $7.07M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest as first filed |
|---|---|---|
| 2026-06-30 | -$2.35M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | -$1.10M 10-Q · filed 2026-08-12 | |
| 2025-12-31 | $4.44M 10-Q · filed 2026-02-11 | |
| 2025-09-30 | $7.07M 10-Q · filed 2026-02-11 | |
| 2025-06-30 | $9.54M 10-Q · filed 2026-08-12 | |
| 2025-03-31 | $10.49M 10-Q · filed 2026-08-12 | |
| 2024-12-31 | $364.00K 10-Q · filed 2026-02-11 | |
| 2024-09-30 | $3.68M 10-Q · filed 2026-02-11 | |
| 2024-06-30 | $6.66M 10-Q · filed 2026-02-11 | |
| 2024-03-31 | $3.60M 10-K · filed 2026-07-14 | |
| 2023-12-31 | $6.18M 10-Q · filed 2025-02-19 | |
| 2023-09-30 | $8.46M 10-Q · filed 2025-02-19 | |
| 2023-06-30 | $11.78M 10-Q · filed 2025-02-19 | |
| 2023-03-31 | $15.33M 10-K · filed 2025-06-05 | |
| 2022-12-31 | $22.29M 10-Q · filed 2024-02-08 | |
| 2022-09-30 | $25.01M 10-Q · filed 2024-02-08 | |
| 2022-06-30 | $27.65M 10-Q · filed 2024-02-08 | |
| 2022-03-31 | $30.21M 10-K · filed 2024-05-31 | |
| 2021-12-31 | $31.29M 10-Q · filed 2023-02-09 | |
| 2021-09-30 | $34.21M 10-Q · filed 2023-02-09 | |
| 2021-06-30 | $37.33M 10-Q · filed 2023-02-09 | |
| 2021-03-31 | $39.20M 10-K · filed 2023-07-14 | |
| 2020-12-31 | $20.75M 10-Q · filed 2022-02-14 | |
| 2020-09-30 | $19.99M 10-Q · filed 2022-02-14 | |
| 2020-06-30 | $24.79M 10-Q · filed 2022-02-14 | |
| 2020-03-31 | $26.63M 10-K · filed 2022-06-10 | |
| 2019-12-31 | $28.95M 10-Q · filed 2021-02-08 | |
| 2019-09-30 | $31.07M 10-Q · filed 2021-02-08 | |
| 2019-06-30 | $36.14M 10-Q · filed 2021-02-08 | |
| 2019-03-31 | $36.30M 10-K · filed 2021-06-15 | |
| 2018-12-31 | $35.67M 10-Q · filed 2020-02-10 | |
| 2018-09-30 | $38.87M 10-Q · filed 2020-02-10 | |
| 2018-06-30 | $41.36M 10-Q · filed 2020-02-10 | |
| 2018-03-31 | $44.59M 10-K · filed 2020-05-28 | |
| 2017-03-31 | $62.36M 10-K · filed 2019-06-03 | |
| 2016-03-31 | $62.18M 10-K · filed 2018-05-31 | |
| 2015-03-31 | $48.70M 10-K · filed 2018-05-31 | |
| 2014-03-31 | $48.28M 10-K · filed 2017-06-07 | |
| 2013-12-31 | $48.70M 10-Q · filed 2014-02-06 | |
| 2013-09-30 | $51.94M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $6.91M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $8.97M 10-K · filed 2016-06-09 | |
| 2012-12-31 | -$5.30M 10-K · filed 2015-06-09 | |
| 2012-09-30 | -$27.42M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | -$71.76M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | -$37.39M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | -$1.83M 10-K · filed 2015-06-09 | -$70.77K 10-Q · filed 2012-01-17 |
| 2011-09-30 | -$28.56K 10-Q · filed 2011-10-31 | |
| 2011-06-30 | -$6.42K 10-Q · filed 2012-01-17 | |
| 2010-12-31 | -$2.30M 10-K · filed 2014-06-10 | -$2.30M 10-Q · filed 2012-05-15 |
| 2010-06-30 | $136.13K 10-Q · filed 2012-01-17 | |
| 2009-12-31 | -$966.00K 10-K · filed 2014-06-10 | -$965.52K 10-Q · filed 2012-05-15 |
| 2009-12-15 | $0.00 10-Q · filed 2012-01-17 | |
| 2009-12-14 | $0.00 10-Q · filed 2011-10-31 | |
| 2008-12-31 | -$96.00K 10-K · filed 2014-06-10 | -$95.82K 10-Q · filed 2012-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |